title: Author's Reply.
authors: Department of Pediatrics, The First Affiliated Hospital of Guangxi Medical University, Nanning, PR China.
authors: Danyan
authors: D
authors: Su
authors: Kai
authors: K
authors: Wang
authors: Suyuan
authors: S
authors: Qin
authors: Yusheng
authors: Y
authors: Pang
mesh_terms: D000925:Anticoagulants / Q000627:therapeutic use*; D001241:Aspirin / Q000627:therapeutic use*; D003323:Coronary Aneurysm / Q000188:drug therapy*; D006801:Humans; D009080:Mucocutaneous Lymph Node Syndrome / Q000150:complications*; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D014859:Warfarin / Q000627:therapeutic use*
chemical_list: D000925:Anticoagulants; D010975:Platelet Aggregation Inhibitors; D014859:Warfarin; D001241:Aspirin